Vaxart Ramps Up Coronavirus Vaccine Production
Vaxart (NASDAQ: VXRT) is gearing up for a potential roll-out of its experimental COVID-19 vaccine.
The clinical-stage biotechnology company is expanding its partnership with Kindred Biosciences (NASDAQ: KIN) to manufacture its oral vaccine candidate for the novel coronavirus. Under the terms of the deal, Kindred's plants will produce bioreactors for Vaxart's clinical trials.
Source Fool.com